{"SPECIMEN TYPE": "SPECIMEN TYPE Blood", "SPECIMEN SITE": "SPECIMEN", "REPORT DATE": "30 Nov 2021", "Biomarker Findings": ["Blood Tumor Mutational Burden - 25 Muts/Mb", "Microsatellite status - MSI-High Not Detected", "Tumor Fraction - 21%", ""], "Genomic Findings": ["For a complete list of the genes assayed, please refer to the Appendix.", "AKT2 amplification", "STK11 Q220*", "CCNE1 amplification - equivocal1 t", "CIC E1356*", "MUTYH Q216*", "RB1 R355fs*6", "TP53 M246L", ""], "Blood Tumor Mutational Burden - 25": [["Atezolizumab", "Cemiplimab", "Durvalumab", "Nivolumab", "Pembrolizumab", "Dostarlimab"], ["Avelumab"]]}